• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NCCN, McKesson Specialty Health, U.S. Oncology Network integrate with Elekta, Varian

NCCN, McKesson Specialty Health, U.S. Oncology Network integrate with Elekta, Varian

September 25, 2013
CenterWatch Staff

The National Comprehensive Cancer Network (NCCN), The U.S. Oncology Network and McKesson Specialty Health have inked agreements to provide future integration with Elekta and Varian that will enhance the ability to provide cancer patients with evidence-based quality care. The two oncology information systems are Elekta’s MOSAIQ and Varian’s ARIA.

Value Pathways Powered by NCCN, which are incorporated into the Clear Value Plus software, will expand next year to include radiation oncology. These clinical practice guidelines are jointly developed by McKesson Specialty Health, The U.S. Oncology Network and NCCN to consider efficacy and cost when evaluating treatment options in radiation oncology, building upon the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and The U.S. Oncology Network’s Level I Pathways.

Clear Value Plus, a clinical quality and regimen support system, allows physicians to access transparent, evidence-based clinical content at the point of care. It is fully embedded into McKesson Specialty Health’s iKnowMed Generation 2SM EHR and will be integrated with MOSAIQ and ARIA. The agreements to integrate the Elekta and Varian oncology information systems with the Clear Value Plus platform in an open, standards-based integration of technology will provide physicians with access to quality support and reporting solutions, as well as Value Pathways treatment options. Through Value Pathways, physicians can gain access to national best practices for optimal patient care and value-based outcomes that are grounded in clinical evidence and the NCCN Guidelines.

The expansion of Value Pathways to include radiation oncology pathways makes these agreements to integrate with Elekta and Varian especially timely. Given the increasing complexity of cancer care and number of radiation treatment options, radiation oncology pathways can be integral in keeping oncologists informed of new developments that may contribute to optimal outcomes.

Robert W. Carlson, M.D., chief executive officer of NCCN, said, “Patient outcomes hinge on the availability of consistent, evidence-based guidance. We see radiation oncology pathways as a needed extension of our NCCN Guidelines, which are widely accepted among providers and payers alike.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing